Home › Vertex sinks after FDA freezes portion of hepatitis drug trial
 

Keywords :   


Vertex sinks after FDA freezes portion of hepatitis drug trial

2013-07-26 19:57:48| Biotech - Topix.net

Investors pounded Vertex Pharmaceuticals in after-hours trading Thursday after the company announced that the U.S. Food and Drug Administration had placed a partial hold on a drug trial for a hepatitis C therapy that may have contributed to liver toxicity in some patients.

Tags: trial drug portion fda

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.09Eastern North Pacific Tropical Weather Outlook
28.09Atlantic Tropical Weather Outlook
28.09Post-Tropical Cyclone Helene Public Advisory Number 21
28.09Tropical Storm Joyce Public Advisory Number 5
28.09Summary for Tropical Storm Joyce (AT1/AL112024)
28.09Post-Tropical Cyclone Helene Public Advisory Number 21
28.09Tropical Storm Joyce Forecast Discussion Number 5
28.09Tropical Storm Joyce Wind Speed Probabilities Number 5
More »